These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 24842338)
1. Toward a personalized medicine approach to the management of inflammatory bowel disease. Mosli MH; Sandborn WJ; Kim RB; Khanna R; Al-Judaibi B; Feagan BG Am J Gastroenterol; 2014 Jul; 109(7):994-1004. PubMed ID: 24842338 [TBL] [Abstract][Full Text] [Related]
2. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine. Su C; Lichtenstein GR Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535 [TBL] [Abstract][Full Text] [Related]
3. Monitoring of azathioprine/6-mercaptopurine treatment in children with IBD is not necessary. Griffiths AM Inflamm Bowel Dis; 2003 Nov; 9(6):389-91; discussion 392-3. PubMed ID: 14671489 [No Abstract] [Full Text] [Related]
4. Monitoring of AZA/6-MP treatment in children with IBD is necessary. Dubinsky MC Inflamm Bowel Dis; 2003 Nov; 9(6):386-8; discussion 392-3. PubMed ID: 14671488 [No Abstract] [Full Text] [Related]
5. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects]. Schwab M; Herrlinger K; Schaeffeler E; Stange EF Dtsch Med Wochenschr; 2003 Feb; 128(8):378-85. PubMed ID: 12594624 [No Abstract] [Full Text] [Related]
6. Medical therapy of IBD in 2009. Harris A; Feller ER; Shah SA Med Health R I; 2009 Mar; 92(3):78-81. PubMed ID: 19385382 [No Abstract] [Full Text] [Related]
8. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease? Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy. Gilissen LP; Wong DR; Engels LG; Bierau J; Bakker JA; Paulussen AD; Romberg-Camps MJ; Stronkhorst A; Bus P; Bos LP; Hooymans PM; Stockbrügger RW; Neef C; Masclee AA J Crohns Colitis; 2012 Jul; 6(6):698-707. PubMed ID: 22398098 [TBL] [Abstract][Full Text] [Related]
10. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study. Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984 [TBL] [Abstract][Full Text] [Related]
11. Drug resistance in inflammatory bowel diseases. Moreau J; Mas E Curr Opin Pharmacol; 2015 Dec; 25():56-61. PubMed ID: 26645664 [TBL] [Abstract][Full Text] [Related]
12. A triangulation study of the clinician and patient experiences of the use of the immunosuppressant drugs azathioprine and 6-mercaptopurine for the management of inflammatory bowel disease. Holbrook K J Clin Nurs; 2007 Aug; 16(8):1427-34. PubMed ID: 17655530 [TBL] [Abstract][Full Text] [Related]
13. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD. Seidman EG Rev Gastroenterol Disord; 2003; 3 Suppl 1():S30-8. PubMed ID: 12684587 [TBL] [Abstract][Full Text] [Related]
14. [Optimized thiopurine treatment in chronic inflammatory bowel disease]. Kiszka-Kanowitz M; Theede K; Nielsen AM Ugeskr Laeger; 2015 Jun; 177(26):1253-5. PubMed ID: 26550625 [TBL] [Abstract][Full Text] [Related]
15. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate. Sandborn WJ Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486 [No Abstract] [Full Text] [Related]
17. The role of thiopurine metabolite monitoring in inflammatory bowel disease. Beswick L; Friedman AB; Sparrow MP Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):383-92. PubMed ID: 24684593 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic Drug Monitoring in Pediatric IBD: Current Application and Future Perspectives. Lega S; Bramuzzo M; Dubinsky MC Curr Med Chem; 2018; 25(24):2840-2854. PubMed ID: 28901267 [TBL] [Abstract][Full Text] [Related]
19. Review article: monitoring of immunomodulators in inflammatory bowel disease. Aberra FN; Lichtenstein GR Aliment Pharmacol Ther; 2005 Feb; 21(4):307-19. PubMed ID: 15709982 [TBL] [Abstract][Full Text] [Related]